Skip to main navigation Skip to search Skip to main content

Urotensin II: Molecular mechanisms of biological activity

  • Andrey A. Svistunov
  • , Vadim V. Tarasov
  • , Svetlana A. Shakhmardanova
  • , Susanna S. Sologova
  • , Ekaterina T. Bagaturiya
  • , Vladimir N. Chubarev
  • , Pavel A. Galenko-Yaroshevsky
  • , Marco Fidel Ávila-Rodriguez
  • , George E. Barreto
  • , Gjumrakch Aliev
  • Sechenov First Moscow State Medical University
  • Russian Ministry of Health
  • Universidad del Tolima
  • Universidad Javeriana
  • Universidad Autónoma de Chile
  • GALLY International Biomedical Research Consulting LLC
  • University of Atlanta
  • Russian Academy of Sciences

Research output: Contribution to journalReview articlepeer-review

Abstract

Urotensin II (UT II) is an important factor of cellular homeostasis. This regulatory peptide is involved in the pathophysiology of many disorders. For example, it plays an important role in the pathogenesis of acute and chronic diseases, stressful and adaptive reactions of the body, in the development of cardiovascular pathologies, metabolic syndrome, inflammation, liver cirrhosis, renal failure, diabetic nephropathy, reproductive dysfunction, progression of psychosomatic, psychoendocrinal and psychiatric disorders. In this concern, the involvement of UT II in the pathophysiology of many processes determines the perspectives for the development of blockers of urotensin receptors for the treatment of the aforementioned diseases. It is important that even today this kind of perspective is feasible due to the synthesis of a series of GPR14 blockers. The objective of this review is to discuss current molecular mechanisms of biological activity, regulatory functions of UT II, its role in the pathogenesis of different nosologies, as well as analysis of the possible routes of exposure to GPR14 as potential therapeutic targets.

Original languageEnglish
Pages (from-to)924-934
Number of pages11
JournalCurrent Protein and Peptide Science
Volume19
Issue number9
DOIs
Publication statusPublished - 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cancer
  • Drug design
  • G-protein-coupled receptors
  • Hormonal systems
  • Kidney
  • Molecular targets of Urotensin II in cardiovascular
  • Nervous
  • Regulatory peptides
  • Sexual function
  • Stress
  • Urotensin II

Fingerprint

Dive into the research topics of 'Urotensin II: Molecular mechanisms of biological activity'. Together they form a unique fingerprint.

Cite this